Announcements

Senior Vice President Noland Rone Jr. filed a Form 4 with the SEC on August 5, 2026, reporting the exercise of stock options and a same-day sale of Class A Common Stock in Donegal Group Inc. (NASDAQ: DGICA) on August 4, 2026.

A Form 4 filed on August 5, 2026 reports that Dennis Joseph Bixenman, a director of Donegal Group Inc (NASDAQ: DGICA), exercised stock options and sold Class A Common Stock on August 4, 2026.

Director Jeffrey W. Yingling filed a Form 4 with the SEC on August 5, 2026, disclosing the acquisition of 524 shares of NorthWestern Energy Group, Inc. (NASDAQ: NWE) common stock on August 4, 2026, as part of the company's non-employee director compensation program.

Linda M. Biles, Executive Vice President of Finance at M-tron Industries, Inc., filed a Form 4 on August 5, 2026, disclosing the acquisition of restricted common shares and the holding of stock options in the company.

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NASDAQ: NRIX), filed a Form 4 on August 5, 2026, reporting the sale of 4,111 shares of common stock on August 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Cameron Pforr, CEO and CFO of M-tron Industries, Inc. (MPTI), filed a Form 4 on August 5, 2026, disclosing the acquisition of restricted shares on March 19, 2026, and the beneficial ownership of stock options granted on April 4, 2026.

William Arnold Drafts, President of M-tron Industries, Inc. (MPTI), filed a Form 4 on August 5, 2026, reporting the acquisition of restricted common stock and the holding of stock options as of transactions dated March 19, 2026 and April 4, 2026.